Valeant partners with National Coalition Against Domestic Violence
LAVAL, Quebec — Drug maker Valeant Pharmaceuticals International is joining an effort to oppose domestic violence, the company said Wednesday.
Valeant announced that it had formed a partnership with the National Coalition Against Domestic Violence to help raise awareness of the problem, with plans to donate a portion of sales from Medicis and Obagi products to the organization.
"Domestic violence is an issue that affects us all, and in particular, the number of women impacted every day is staggering," chairman and CEO J. Michael Pearson said. "This partnership provides a platform for us to partner with all stakeholders in the industry, from our employees to the medical community to the consumers who use our products, in the battle to end domestic violence. We are excited about the long-term prospects to improve the lives of women through this initiative."
Introducing State Pharmacy Now — a new digital magazine presented by DSN, NASPA
The Drug Store News Group has partnered with the National Alliance of State Pharmacy Associations to produce State Pharmacy Now, an exciting, new, first-of-its-kind digital magazine and a must-read for pharmacy professionals across the country. Jammed full of informative articles, charts and data, interactive videos, new product reviews in OTC and technology, and leading executive viewpoints on the state of the industry, the premiere edition of State Pharmacy Now features extensive coverage from NACDS Total Store Expo, including Hillary Clinton on the critical role pharmacy will play in health reform, as well as an in-depth look at how medication synchronization is wowing patients and payers, and one pharmacy chain that is racking up improved outcomes and driving script count because of it.
Actavis, Warner Chilcott meet last regulatory requirements for merger
DUBLIN — Ireland’s High Court has approved Actavis’ acquisition of Warner Chilcott, the drug makers said.
The companies said the approval of Irish authorities meant that they had obtained all regulatory approvals required to complete the transaction, and that it now remained subject to satisfaction of other customary closing conditions and would occur as soon as practicable.
Actavis and Warner Chilcott announced the $8.5 billion merger deal in May. The companies’ shareholders voted to approve it on Sept. 10.